Truist Financial
RPRX icon

Truist Financial’s Royalty Pharma RPRX Stock Holding History

Truist Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
29,890
+782
+3% +$40.7K ﹤0.01% 1480
2026
Q1 		$1.4M Buy
29,108
+1,339
+5% +$58.6K ﹤0.01% 1524
2025
Q4 		$1.07M Buy
27,769
+303
+1% +$11.6K ﹤0.01% 1625
2025
Q3 		$969K Buy
27,466
+3,127
+13% +$113K ﹤0.01% 1685
2025
Q2 		$877K Buy
24,339
+847
+4% +$28.1K ﹤0.01% 1653
2025
Q1 		$731K Buy
23,492
+8,953
+62% +$284K ﹤0.01% 1673
2024
Q4 		$371K Buy
+14,539
New +$386K ﹤0.01% 2044
2024
Q3 		– Sell
-13,486
Closed -$356K – 2694
2024
Q2 		$356K Sell
13,486
-10,211
-43% -$283K ﹤0.01% 2198
2024
Q1 		$720K Buy
23,697
+7,909
+50% +$233K ﹤0.01% 1764
2023
Q4 		$443K Buy
+15,788
New +$434K ﹤0.01% 2061
2023
Q2 		– Sell
-38,731
Closed -$1.4M – 2658
2023
Q1 		$1.4M Buy
38,731
+486
+1% +$18K ﹤0.01% 1400
2022
Q4 		$1.51M Sell
38,245
-8,683
-19% -$362K ﹤0.01% 1345
2022
Q3 		$1.89M Buy
46,928
+34,103
+266% +$1.46M ﹤0.01% 1206
2022
Q2 		$539K Buy
+12,825
New +$526K ﹤0.01% 1864

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truist Financial's RPRX Position: Q2 2026 in Review

Truist Financial increased its Royalty Pharma (RPRX) stake by 2.7% in Q2 2026, buying an estimated $40.7K and bringing the position to 29,890 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Truist Financial first reported a position in RPRX in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.89M in Q3 2022. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Truist Financial held 29,890 shares of Royalty Pharma worth $1.68M as of Q2 2026.
  • Truist Financial bought 782 Royalty Pharma shares in Q2 2026, an estimated $40.7K.
  • Royalty Pharma made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1480 holding.
  • Truist Financial first reported a position in Royalty Pharma in Q2 2022 and has held it in 14 quarters since.
  • Truist Financial's Royalty Pharma position peaked at $1.89M in Q3 2022.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.